Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals LtdfiledCriticalIdorsia Pharmaceuticals Ltd
Publication of CL2023000970A1publicationCriticalpatent/CL2023000970A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a los compuestos de la Fórmula (I), en donde Ar1, A, B, y R1 son como se describe en la descripción, su preparación, a sales farmacéuticamente aceptables de los mismos, y a su uso como farmacéuticos, a composiciones farmacéuticas que contienen uno o más compuestos de la fórmula (I), y especialmente a su uso como inhibidores de Galectina-3.The present invention relates to the compounds of Formula (I), where Ar1, A, B, and R1 are as described in the description, their preparation, pharmaceutically acceptable salts thereof, and their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as Galectin-3 inhibitors.
CL2023000970A2020-10-062023-04-04
Spiro derivatives of alpha-d-galactopyranosides
CL2023000970A1
(en)
DERIVATIVES OF 4-PIRAZOL AMIDAS CONTAINING CARBOXI, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE PROCESSES.